Product Information
DORZOLAMIDE-TIMOLOL EYE DROPS is a generic product labeled by Aurobindo Pharma Limited, priced at $0.8927 per ML under NDC 65862094601. Its NADAC has been published 227 times since Jun 1, 2022.
FDA first approved this application on May 14, 2021. Its Orange Book therapeutic-equivalence code is AT1.
Strength
20; 5 mg/mL; mg/mL
Manufacturer
Aurobindo Pharma LimitedNDC
65862094601
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA207629FDA Approved
5/14/2021
TE Code
AT1
On Market Since
5/14/2021
Pharmacological Classes
Price Statistics
The NADAC for DORZOLAMIDE-TIMOLOL EYE DROPS has been published 227 times since Jun 1, 2022, and over the history we have for it it has declined 26.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8927 per ML |
|---|---|
| All-time high | $1.2906 (Jul 13, 2022) |
| All-time low | $0.8853 (Jul 22, 2026) |
| 52-week high | $1.0228 |
| 52-week low | $0.8853 |
| Median price | $1.0758 |
| Average price | $1.0697 |
| Largest weekly change | +16.8% (Jun 19, 2024) |
| Weeks tracked | 227 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dorzolamide Hydrochloride and Timolol Maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Carbonic Anhydrase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DORZOLAMIDE-TIMOLOL EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for DORZOLAMIDE-TIMOLOL EYE DROPS, manufactured by Aurobindo Pharma Limited, is $0.8927 per ML (NDC 65862094601), effective Sep 30, 2026.
How has the price of DORZOLAMIDE-TIMOLOL EYE DROPS changed over time?
Over the history we have for it, the NADAC for DORZOLAMIDE-TIMOLOL EYE DROPS has declined 26.7%. It has been tracked across 227 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for DORZOLAMIDE-TIMOLOL EYE DROPS?
Since Jun 1, 2022, the NADAC for DORZOLAMIDE-TIMOLOL EYE DROPS has ranged from a low of $0.8853 (Jul 22, 2026) to a high of $1.2906 (Jul 13, 2022), with a median of $1.0758 per ML.
Are there cheaper alternatives to DORZOLAMIDE-TIMOLOL EYE DROPS?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DORZOLAMIDE-TIMOLOL EYE DROPS in a comparable dosage form, but none are currently priced below it.
Who manufactures DORZOLAMIDE-TIMOLOL EYE DROPS?
DORZOLAMIDE-TIMOLOL EYE DROPS (NDC 65862094601) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.